I can’t say it any better than Lucinda Marshall did in the e-mail I received accompanying this information:
… let me see if I have this straight. We’re all gung ho to spend $360 to provide HPV vaccine but birth control pills are no longer affordable for those who need them most. How about a tax on every male in this country for the role they play in travesty?
Millions of college students are suddenly facing sharply higher prices for birth control, prompting concerns among health officials that some will shift to less preferred contraceptives or stop using them altogether.
Prices for oral contraceptives, or birth control pills, are doubling and tripling at student health centers, the result of a complex change in the Medicaid rebate law that essentially ends an incentive for drug companies to provide deep discounts to colleges.
“It’s a tremendous problem for our students because not every student has a platinum card,” said Hugh Jessop, executive director of the health center at Indiana University.
There, he said, women are paying about $22 per month for prescriptions that cost $10 a few months ago. “Some of our students have two jobs, have children,” Jessop said. “To increase this by 100 percent or more overnight, which is what happened, is a huge shock to them and to their system.”
At some schools women could see prices rise several hundred dollars per year.
About 39 percent of undergraduate women use oral contraceptives, according to an estimate by the American College Health Association based on survey data.
Many students could shift to generics but experts said they might still pay twice the previous rate.
“It’s terrible, because these are students who are working very hard to pay for their tuition and books at a time when tuition costs are edging up as well,” said Linda Lekawski, director of the university health center at Texas A&M, where the old price for birth control pills of about $15 per month is expected to triple. “This is one thing they’ve been able to benefit from for years.”
The change is the result of a chain reaction started by a 2005 deficit-reduction bill that focused on Medicaid, the main federal health insurance program for the poor. College health officials say they had little idea the bill would affect them.
Before the change, pharmaceutical companies typically sold drugs at deep discounts to a range of health care providers, including colleges. With contraceptives, one motivation was attracting customers who would stay with their products for years.
Another reason the discounts made business sense was that they didn’t count against the drug makers in a formula calculating rebates they owed states to participate in Medicaid.
But in its 2005 bill — which went into effect in January — Congress changed that. Now the discounts to colleges mean drug manufacturers have to pay more to participate in Medicaid.
The result: Fewer companies are willing to offer discounts.